Savitr Capital

Savitr Capital

Savitr Capital is a private equity firm in San Francisco that focuses on investing in renewable and clean energy companies.

Savitr Capital is a private equity firm in San Francisco that focuses on investing in renewable and clean energy companies. Founded in San Francisco, CaliforniaUnited States, it invests in early stage ventures, series B, venture rounds, and series C rounds. Its portfolio companies include OncoCell MDx, Ancora Heart, and Naurex. As of June 2020, Savitr Capital has made four investments. Their most recent investment was on September 11, 2019, when OncoCell MDx raised $22.2M. Savitr Capital has had one exit, which was Naurex. The company’s goal is to provide risk adjusted returns by investing in companies in the clean and renewable energy sectors.

Savitr Capital is actively using 16 technologies for its website. These include Viewport Meta, IPhone / Mobile Compatible, and SSL by Default.

Timeline

September 11, 2019

Their most recent investment was on Sep 11, 2019, when OncoCell MDx raised $22.2M.

September 11, 2019

Their most recent investment was on Sep 11, 2019, when OncoCell MDx raised $22.2M.

2008

Founded

Funded Companies

Company
Description
Industry
Website
Location
Naurex

A company focused on developing therapeutics for the treatment of depression and other central nervous system disorders

OncoCell MDx is a Royal Oak, Michigan-based medical diagnostics company developing an immunogenomic liquid biopsy platform for the early detection of cancer.

Ancora Heart is a Santa Clara, California-based company.

3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Andrew Midler

Founder & Managing Member

Ian Ferrier Ph.D

Advisor

Michael Mormile

Executive, Fund Operations & Accounting

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Ancora Heart

Naurex

OncoCell MDx

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.